Lilium Announces FY and Q4 2023 Shareholder Letter and Webcast on February 27, 2024
MUNICH, Germany, Feb. 14, 2024 (GLOBE NEWSWIRE) — Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM) today announced that it […]
ToughBuilt Industries Announces Pricing of $3.5 Million Public Offering
IRVINE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced […]
BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET
Company announces preliminary fourth-quarter 2023 revenue record in excess of $42 million, as well as a record-breaking full-year 2023 revenue […]
Kornit Digital Reports Fourth Quarter and Full Year 2023 Results
Fourth quarter revenues of $56.6 million, in line with previous guidance Fourth quarter GAAP net loss of $22.9 million; non-GAAP […]
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase […]
Evoke Pharma Announces Closing of $7.5 Million Public Offering
SOLANA BEACH, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments […]
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2023 Earnings and Company Updates
CAMBRIDGE, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on […]
Conduent Recognized as a 2024 Leader in HR Benefits Administration by NelsonHall
NelsonHall says Conduent provides integrated health, financial wellness and total rewards solutions focused on increasing employee engagement Conduent named an […]
Perella Weinberg to Present at the Bank of America 2024 Financial Services Conference
NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — Perella Weinberg Partners (“PWP”) (NASDAQ:PWP), a leading global independent advisory firm, today […]
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
LOS ALTOS, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]
